These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4155865)

  • 1. [Possible use of pyocins against Pseudomonas aeruginosa (author's transl)].
    Sezen IY; Blobel H; Scharmann W
    Zentralbl Bakteriol Orig A; 1974; 229(2):205-8. PubMed ID: 4155865
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relations between antibiotic resistance and pyocin P3 resistance in Pseudomonas aeruginosa mutants].
    García-Quintana HG; Wilckens R
    Zentralbl Veterinarmed B; 1983 Apr; 30(3):169-74. PubMed ID: 6408850
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of Pseudomonas aeruginosa in relation to pyocine typing drug sensitivity and epidemiology.
    Mohanty SK; Bhuyan BK; Nathsarma KC; Nanda BK
    Indian J Pathol Microbiol; 1982 Jan; 25(1):45-9. PubMed ID: 6809612
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibiotic sensitivity and pyocin dependence of clinical strains of Ps. aeruginosa].
    Savitskaia KI; Levina EN
    Antibiotiki; 1977 Dec; 22(12):1117-21. PubMed ID: 413475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pseudomonas aeruginosa strains: synergism and pyocinogenia induction].
    García-Quintana HG; Martińez MA
    Rev Med Chil; 1988 Nov; 116(11):1167-71. PubMed ID: 3151707
    [No Abstract]   [Full Text] [Related]  

  • 6. [A comparison of antibiotic resistance patterns and pyocine types between strains of Pseudomonas aeruginosa from animal and human sources (author's transl)].
    Küchler R; Günther D
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(4):413-20. PubMed ID: 824895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological studies of P. aeruginosa infections by the typing of pyocine sensitivity (author's transl)].
    Dunkelberg H; Schicketanz KH
    Zentralbl Bakteriol Orig B; 1976 Mar; 161(5-6):444-54. PubMed ID: 823741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Level of resistance of clinical isolates of Pseudomonas aeruginosa as related to their susceptibility to phages and R-pyocins.
    Legakis N; Koukoubanis N; Malliara K; Tumah H
    Chemioterapia; 1987 Jun; 6(2 Suppl):200-1. PubMed ID: 3151342
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa.
    Petrocheilou-Malliara K; Koukoubanis N; Legakis N
    Chemioterapia; 1987 Jun; 6(2 Suppl):199. PubMed ID: 3151341
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biological effects of pyocins on Salmonella typhimurium strains inoculated into the mouse].
    García-Quintana HG; Ojeda R; Mancilla JC; Chahuan E
    Zentralbl Veterinarmed B; 1983 May; 30(4):251-7. PubMed ID: 6408851
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyocin types of clinical strains of Pseudomonas aeruginosa isolated in Morelia, México (1980-1984).
    Cervantes Vega C; Chávez J; Padilla ME; Rivera AN; Vaca S
    Rev Latinoam Microbiol; 1986; 28(4):287-91. PubMed ID: 3108986
    [No Abstract]   [Full Text] [Related]  

  • 12. [Second possibility of employing typization of Pseudomonas aeruginosa by means of pyocins (pyocinotypia) (author's transl)].
    Zahradnický J
    Cesk Epidemiol Mikrobiol Imunol; 1979 Nov; 28(6):321-5. PubMed ID: 161865
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phenotypic relations with regard to pyocin sensitivity, of 191 strains of Pseudomonas aeruginosa isolated in a hospital environment].
    Santini G; Targa S; Basaglia M; Marchetti G; Crovatto M
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):242-6. PubMed ID: 6416270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bactericidal spectrum of pyocins on strains collected at Region IX and X hospitals in Chile].
    García-Quintana HG; Polette M; Ríos J
    Rev Med Chil; 1989 Jun; 116(6):543-8. PubMed ID: 2501848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative and qualitative measurement of the activity of pyocins of Ps. aeruginosa (author's transl)].
    García Quintana H; Asenjo S; Hernández A; Polette M
    Rev Med Chil; 1979 Jun; 107(6):471-8. PubMed ID: 120964
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between aminosugars in the lipopolysaccharide, serotype, and aeruginocin sensitivity in strains of Pseudomonas aeruginosa.
    Koval SF; Meadow PM
    J Gen Microbiol; 1975 Dec; 91(2):437-40. PubMed ID: 812944
    [No Abstract]   [Full Text] [Related]  

  • 17. New pyocine-types of Pseudomonas aeruginosa from children's infections.
    Carvajal G; Flores W
    Rev Latinoam Microbiol; 1985; 27(3):177-82. PubMed ID: 3938046
    [No Abstract]   [Full Text] [Related]  

  • 18. [The "in vitro" sensitivity of pseudomonas aeruginosa to antibiotic and chemotherapeutic agents (author's transl)].
    Paredes L; Valenzuela E; Caorsi B; Castillo M
    Rev Med Chil; 1976 Sep; 104(9):615-9. PubMed ID: 828758
    [No Abstract]   [Full Text] [Related]  

  • 19. Plant-expressed pyocins for control of Pseudomonas aeruginosa.
    Paškevičius Š; Starkevič U; Misiūnas A; Vitkauskienė A; Gleba Y; Ražanskienė A
    PLoS One; 2017; 12(10):e0185782. PubMed ID: 28973027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of various antibiotics and the new gentamicin preparation against various pathogenic microbes].
    Jedlicková Z; Výmola F
    Zentralbl Bakteriol Orig; 1968; 208(3):462-6. PubMed ID: 4988546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.